# A Study of STSA-1201 in Healthy Subjects

> **NCT05986877** · PHASE1 · COMPLETED · sponsor: **Staidson (Beijing) Biopharmaceuticals Co., Ltd** · enrollment: 44 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** STSA-1201 Subcutaneous injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05986877
- **Lead sponsor:** Staidson (Beijing) Biopharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-04
- **Primary completion:** 2024-03-14
- **Final completion:** 2024-03-14
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05986877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05986877, "A Study of STSA-1201 in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05986877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*